Prova Storytel gratis i 30 dagar Ett universum fyllt av ljudböcker, klicka här för att komma igång

RARECast

En podcast av: RARECast

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy

Our American listeners can also listen to RARECast at our American site

516 Avsnitt

A Gene Therapy Company Born from a Father’s Efforts to Save his Daughter
Publicerades 2024-11-07

Lowering Barriers to Clinical Trial Participation with Do-It-Yourself Blood Sample Collection
Publicerades 2024-10-31
Scaling N-of-1 Therapies to Viability
Publicerades 2024-10-24
Building Gene Therapies that Address Gain and Loss of Function Simultaneously
Publicerades 2024-10-17
How One Woman Climbed from Patient to Advocate
Publicerades 2024-10-10
Shortening the Diagnostic Odyssey
Publicerades 2024-10-03
Making Exomes More Revealing
Publicerades 2024-09-26
How One Patient Organization Catalyzed Drug Development
Publicerades 2024-09-19
Enabling On-Demand Therapies
Publicerades 2024-09-16
After Driving an N-of-1 Therapy for Her Son, an Advocate Turns to Helping Others
Publicerades 2024-09-05
Putting Rare Disease Organization in the Business of Drug Development
Publicerades 2024-08-29
Understanding the Many Questions Gene Therapies Raise
Publicerades 2024-08-22
A Test to Identify People Likely to Develop ALS
Publicerades 2024-08-15
How an Ultra-Rare Disease Patient Foundation Advanced a Gene Therapy
Publicerades 2024-08-08
Making the $10 Genome a Reality
Publicerades 2024-08-01
A No-Nonsense Effort to Develop a Therapy that Works Across Genetic Diseases
Publicerades 2024-07-25
Mapping a Perilous Journey with Humor
Publicerades 2024-07-18
Restoring Vision in Inherited Retinal Disease
Publicerades 2024-07-11
Bringing Genome Sequencing to Rural Populations
Publicerades 2024-07-04
Addressing a Blind Spot in Treatments for the Cornea
Publicerades 2024-06-27

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

516 Avsnitt

A Gene Therapy Company Born from a Father’s Efforts to Save his Daughter

Lowering Barriers to Clinical Trial Participation with Do-It-Yourself Blood Sample Collection

Scaling N-of-1 Therapies to Viability

Building Gene Therapies that Address Gain and Loss of Function Simultaneously

How One Woman Climbed from Patient to Advocate

Shortening the Diagnostic Odyssey

Making Exomes More Revealing

How One Patient Organization Catalyzed Drug Development

Enabling On-Demand Therapies

After Driving an N-of-1 Therapy for Her Son, an Advocate Turns to Helping Others

Putting Rare Disease Organization in the Business of Drug Development

Understanding the Many Questions Gene Therapies Raise

A Test to Identify People Likely to Develop ALS

How an Ultra-Rare Disease Patient Foundation Advanced a Gene Therapy

Making the $10 Genome a Reality

A No-Nonsense Effort to Develop a Therapy that Works Across Genetic Diseases

Mapping a Perilous Journey with Humor

Restoring Vision in Inherited Retinal Disease

Bringing Genome Sequencing to Rural Populations

Addressing a Blind Spot in Treatments for the Cornea